In a study of newborn piglets, infection with influenza A was associated with disruptions in the piglets' nasal and gut ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

Approval of Enflonsia was based on data from the Phase IIb/III CLEVER trial, which showed a 60.5% reduction in medically ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...

Integrated DNA Technologies (IDT), a global genomics provider headquartered in Coralville, is expanding its infectious ...

(Emily Fitzpatrick/CBC) For the first time since the start of the COVID-19 pandemic, the number of Nova Scotians dying from influenza exceeds the number of COVID deaths. According to the province ...

The approval was based on data from the pivotal Phase IIb/III CLEVER trial which assessed a single dose of the antibody.